Gene profiling and prediction of response to anastrozole neoadjuvant treatment in breast cancer
Source: NCBI BioProject (ID PRJNA118149)

0 0

Project name: Homo sapiens
Description: Transcriptome of 17 tru-cut biopsies and 13 matched surgical samples from ER+ breast tumor patients, treated for 3 months with Anastrozole were anayzed to identify a robust expression signature predictive of response to Anastrozole neoadjuvant treatment in ER+ breast cancer patients and, at the same time, to delineate treatment effects.Overall design: Each specimen had been hybridized against a Human universal reference used as baseline in each array. Two replicates with dye-swap had been performed for each sample, both before (tru-cut biopsy sample) and after treatment (surgical sample).
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Cancer Genomics Laboratory, Fondazione "Edo ed Elvo Tempia Valenta"
Literatures
  1. PMID: 20428938
Release date: 2010-05-17
Last updated: 2009-10-02